URETERIC STENT-RELATED MORBIDITY

Clinical trials for URETERIC STENT-RELATED MORBIDITY explained in plain language.

Never miss a new study

Get alerted when new URETERIC STENT-RELATED MORBIDITY trials appear

Sign up with your email to follow new studies for URETERIC STENT-RELATED MORBIDITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy may offer better relief for stent sufferers

Symptom relief Completed

This study tested two drugs—mirabegron and tamsulosin—alone or together, to see which works best for reducing pain and urinary symptoms caused by a ureteral stent. 300 adults who had a stent for the first time took part. The goal was to find a treatment with fewer side effects th…

Matched conditions: URETERIC STENT-RELATED MORBIDITY

Phase: NA • Sponsor: Avraiem Talaat • Aim: Symptom relief

Last updated May 04, 2026 04:18 UTC

URETERIC STENT-RELATED MORBIDITY

Get alerted when new URETERIC STENT-RELATED MORBIDITY trials appear

New combo therapy may offer better relief for stent sufferers